These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 327545)

  • 21. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli.
    Dionysius DA; Grieve PA; Milne JM
    J Dairy Sci; 1993 Sep; 76(9):2597-600. PubMed ID: 8227660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of lactoferrin interaction with Streptococcus mutans.
    Lassiter MO; Newsome AL; Sams LD; Arnold RR
    J Dent Res; 1987 Feb; 66(2):480-5. PubMed ID: 3114344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of human monocyte chemiluminescence by iron-saturated lactoferrin.
    Ito M; Bognacki J; Broxmeyer H; DeSousa M; Hadden JW
    Int J Immunopharmacol; 1983; 5(4):359-64. PubMed ID: 6629597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin.
    Clarke SR; Foster SJ
    Infect Immun; 2008 Apr; 76(4):1518-26. PubMed ID: 18227165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prooxidant activity of transferrin and lactoferrin.
    Klebanoff SJ; Waltersdorph AM
    J Exp Med; 1990 Nov; 172(5):1293-303. PubMed ID: 2230644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergic antistaphylococcal properties of lactoferrin and lysozyme.
    Leitch EC; Willcox MD
    J Med Microbiol; 1998 Sep; 47(9):837-42. PubMed ID: 9736166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface.
    Dalmastri C; Valenti P; Visca P; Vittorioso P; Orsi N
    Microbiologica; 1988 Jul; 11(3):225-30. PubMed ID: 2971856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
    Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
    Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice.
    Velusamy SK; Fine DH; Velliyagounder K
    Microbes Infect; 2014 Sep; 16(9):762-7. PubMed ID: 25124544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactoferrin-mediated transfer of iron to intracellular ferritin in human monocytes.
    Birgens HS; Kristensen LO; Borregaard N; Karle H; Hansen NE
    Eur J Haematol; 1988 Jul; 41(1):52-7. PubMed ID: 3402586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cofactor requirements for expression of lactoferrin bactericidal activity on enteric bacteria.
    Motley MA; Arnold RR
    Adv Exp Med Biol; 1987; 216A():591-9. PubMed ID: 3318290
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of novel formulations containing Lysozyme and Lactoferrin and evaluation of antibacterial effects on Mutans Streptococci and Lactobacilli.
    Tonguc-Altin K; Sandalli N; Duman G; Selvi-Kuvvetli S; Topcuoglu N; Kulekci G
    Arch Oral Biol; 2015 May; 60(5):706-14. PubMed ID: 25757148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organism.
    Bortner CA; Arnold RR; Miller RD
    Can J Microbiol; 1989 Nov; 35(11):1048-51. PubMed ID: 2692799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriostasis of Escherichia coli by bovine lactoferrin, transferrin and immunoglobulins (IgG1, IgG2, IgM) acting alone or in combination.
    Rainard P
    Vet Microbiol; 1986 Feb; 11(1-2):103-15. PubMed ID: 3518222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of lactoferrin, an iron-binding protein on complement activity.
    Morgan OS; Bankay J; Quash GA
    West Indian Med J; 1975 Mar; 24(1):46-54. PubMed ID: 1169861
    [No Abstract]   [Full Text] [Related]  

  • 36. Susceptibilities of lactoferrin and transferrin to myeloperoxidase-dependent loss of iron-binding capacity.
    Winterbourn CC; Molloy AL
    Biochem J; 1988 Mar; 250(2):613-6. PubMed ID: 2833250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production.
    Broxmeyer HE; Smithyman A; Eger RR; Meyers PA; de Sousa M
    J Exp Med; 1978 Oct; 148(4):1052-67. PubMed ID: 308988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activity and synergism of lactoferrin and lysozyme against cariogenic microorganisms.
    de Andrade FB; de Oliveira JC; Yoshie MT; Guimarães BM; Gonçalves RB; Schwarcz WD
    Braz Dent J; 2014; 25(2):165-9. PubMed ID: 25140723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.
    Mirza S; Wilson L; Benjamin WH; Novak J; Barnes S; Hollingshead SK; Briles DE
    Infect Immun; 2011 Jun; 79(6):2440-50. PubMed ID: 21422179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of human myelopoiesis by prostaglandin E and lactoferrin.
    Pelus LM; Broxmeyer HE; Moore MA
    Cell Tissue Kinet; 1981 Sep; 14(5):515-26. PubMed ID: 7273093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.